Opioid‐induced microbial dysbiosis disrupts irinotecan (CPT‐11) metabolism and increases gastrointestinal toxicity in a murine model
British Journal of Pharmacology · 2023
DOI: 10.1111/bph.16020 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2023. Verfasst von Jingjing Meng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Miami, Miami, Florida, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Phytogenic, Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background and Purpose Opioids are commonly used for the management of cancer‐associated pain and chemotherapy‐induced diarrhoea. The chemotherapeutic irinotecan (CPT‐11) causes severe gastrointestinal (GI) toxicity due to deconjugation of inactive metabolite SN‐38 glucuronide (SN‐38G) by bacterial β‐glucuronidases to the active 7‐ethyl‐10‐hydroxycamptothecin (SN‐38). Opioids are known to cause gut microbial dysbiosis, this study evaluated whether CPT‐11 anti‐tumour efficacy and GI toxicity are exacerbated by opioid co‐administration. Experimental Approach Eight‐week‐old C57BL/6 male mice were co‐administration with CPT‐11 ± opioid. 16S rRNA sequencing was used for gut microbiome analysis. LC–MS analyses of plasma and intestinal extracts were performed to investigate the pharmacokinetic profile of CPT‐11. Histological analysis and quantitative real‐time polymerase chain reaction were used to determine the severity of intestinal tissue damage. Human liver microsome In vitro assay was performed to confirm the effects of opioids on CPT‐11 metabolism. Key Results Gut microbiome analysis showed that morphine treatment induced enrichment of β‐glucuronidase‐producing bacteria in the intestines of CPT‐11‐treated mice, resulting in SN‐38 accumulation and exacerbation of GI toxicity in the small intestine. Oral administration of both antibiotics and glucuronidase inhibitor protected mice against GI toxicity induced with CPT‐11 and morphine co‐administration, implicating a microbiome‐dependent mechanism. Additionally, morphine and loperamide decreased the plasma concentration of SN‐38 and compromised CPT‐11 anti‐tumour efficacy, this seemed to be microbiome independent. Conclusion and Implications Gut microbiota play a significant role in opioid and chemotherapeutic agent drug–drug interactions. Inhibition of gut microbial glucuronidase may also prevent adverse GI effects of CPT‐11 in patients on opioids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, University of Miami, Miami, Florida, USA.
- Department of Microbiology and Immunology, University of Miami, Miami, Florida, USA.
- Department of Food Science and Nutrition, University of Minnesota, Minneapolis, Minnesota, USA.
ORCID-Profile: Junyi Tao
Förderung
- NIDA NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Meng, J., Abu, Y. F., Zhang, Y., Zhou, Y., Xie, Y., Yan, Y., Tao, J., Ramakrishnan, S., Chen, C., & Roy, S. (2023). Opioid‐induced microbial dysbiosis disrupts irinotecan (CPT‐11) metabolism and increases gastrointestinal toxicity in a murine model. British Journal of Pharmacology. https://doi.org/10.1111/bph.16020
Vancouver
Meng J, Abu YF, Zhang Y, Zhou Y, Xie Y, Yan Y, et al. Opioid‐induced microbial dysbiosis disrupts irinotecan (CPT‐11) metabolism and increases gastrointestinal toxicity in a murine model. British Journal of Pharmacology. 2023. doi:10.1111/bph.16020
BibTeX
@article{Meng2023,
author = {Meng, Jingjing and Abu, Yaa F and Zhang, Yue and Zhou, Yuyin and Xie, Yun and Yan, Yan and Tao, Junyi and Ramakrishnan, Sundaram and Chen, Chi and Roy, Sabita},
title = {Opioid‐induced microbial dysbiosis disrupts irinotecan (CPT‐11) metabolism and increases gastrointestinal toxicity in a murine model},
journal = {British Journal of Pharmacology},
year = {2023},
doi = {10.1111/bph.16020}
}
EUVIMED